- Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
- Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease
- Screening for Genes in Patients With Congenital Neutropenia
- Total Lymphoid Irradiation Pre-HSCT in Severe Congenital Neutropenia
Clinical Trials
- A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-Resminostat
- AEDV Registry of Primary Cutaneous Lymphoma
- Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies
- Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome
- Evolution of the SURvival of Patients With SEzary Syndrome (SS) Over the 1998-2020 Period and Its Association With the Early Use of Therapeutic Monoclonal Antibodies
- Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
- Extracorporeal Photopheresis in Sezary Syndrome
- Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
- Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome
- Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides
- Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
- Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome
- A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.
- Ciprofloxacin Versus Azithromycin for Children Hospitalised With Dysentery
- Controlled Human Infection Model Challenge/Rechallenge
- Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders
- Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years
- Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults
- Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a
- Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis
- Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR) Administered Intranasally to Healthy, Adult Volunteers
- Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella
- Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a
- Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults
- Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel
- SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers
- Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection
- Shigella Sonnei OSPC-rDT Conjugate Vaccine
- Shigella Sonnel O-SPC/rBRU Conjugate Vaccine
- Tebipenem Trial in Children With Shigellosis
- Therapeutic Induction of Endogenous Antibiotics
- A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
- A Blood Stem Cell Transplant for Sickle Cell Disease
- A Brief Laboratory-Based Hypnosis Session for Pain in Sickle Cell Disease
- A Comprehensive Care Plan for Pediatric Patients With Vaso-Occlusive Crises
- A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease
- A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001)
- A Long-term Follow-up Study in Subjects Who Received CTX001
- A Longitudinal Survey Study on Living With Sickle Cell Disease in the COVID-19 Pandemic
- A Multi-Center Study of Riociguat in Patients With Sickle Cell Diseases
- A New Reagent Assay Examining Natural Parvovirus B19 Infection in Sickle Cell Disease
- A Phase – IIa – IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCD
- A Phase 1 Study of Continuous Intravenous L-citrulline During Sickle Cell Pain Crisis or Acute Chest Syndrome
- A Phase 1/2, Open-Label, Dose Escalating Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AB1 in Adult Patients With Sickle Cell Disease (SCD)
- A Phase 2 Study of the Effects of 6R-BH4 in Subjects With Sickle Cell Disease
- A Phase 2/3 Study in Adult and Pediatric Participants With Sickle Cell Disease (SCD)
- A Phase 2a Study to Assess Efficacy and Safety of VIT-2763 in Subjects With Sickle Cell Disease
- A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders
- A Phase Ib Study of NVX-508 in Sickle Cell Disease
- A Phase II Trial of Regadenoson in Sickle Cell Anemia
- A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
- A Pilot Study of Azithromycin Prophylaxis for Acute Chest Syndrome in Sickle Cell Disease
- A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary Hypertension
- A Pilot Study of Fecal Microbiome and Neutrophil Cellular Adhesion Molecules in Patients With Sickle Cell Disease (SCD)
- A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen
- A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease
- A Pilot Study on Neuroimaging in SCD: Part of The Boston Consortium to Cure Sickle Cell Disease
- A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)
- A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease
- A Rehabilitation Program in Children With Sickle Cell Disease and Cognitive Deficits: a Pilot Study
- A Relative Bioavailability Study of a Prasugrel Orally Disintegrating Tablet
- A SAD/MAD to Assess the Safety, Pharmacokinetics and Pharmacodynamics of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients
- A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease
- A Safety Study of Eptifibatide in Patients With Sickle Cell Disease
- A Sickle CEll Disease ComplicatioN Trial
- A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease
- A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects
- A Stratified Sickle Event Randomized Trial (ASSERT)
- A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
- A Study Aimed to Assess the Needs of Subjects With Sickle Cell Disease and Healthcare Professionals Managing Sickle Cell Disease Patients in Selected Nigerian Centres
- A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease
- A Study Evaluating the Efficacy and Safety of LentiGlobin BB305 Drug Product in Beta-Thalassemia Major and Sickle Cell Disease
- A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease
- A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD)
- A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy
- A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in Severe Sickle Cell Disease
- A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOE) in Participants With Sickle Cell Disease (SCD).
- A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises
- A Study of FT-4202 in Adults and Adolescents With Sickle Cell Disease
- A Study of FT-4202 in Patients With Thalassemia or Sickle Cell Disease
- A Study of HQK-1001 in Patients With Sickle Cell Disease
- A Study of IMR-687 in Adult Patients With Sickle Cell Anaemia (Homozygous HbSS or Sickle-β0 Thalassemia)
- A Study of IMR-687 in Healthy Adult Volunteers
- A Study of IMR-687 in Subjects With Sickle Cell Disease
- A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
- A Study of Oral L-citrulline in Sickle Cell Disease
- A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study
- A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease
- A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)
- A Study of SHP655 (rADAMTS13) in Sickle Cell Disease
- A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)
- A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.
- A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease
- A Study of Varespladib Infusion in Subjects With Sickle Cell Disease.
- A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell Disease
- A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises
- A Study to Assess the Safety, Tolerability, and Efficacy of BIVV003 for Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Sickle Cell Disease
- A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered
- A Study to Evaluate an Electronic Patient Diary in Adult Participants With Sickle Cell Disease
- A Study to Evaluate GBT021601 in Single and Multiple Doses in Healthy Participants
- A Study to Evaluate GBT021601-012 Single Dose and Multiple Dose in Participants With Sickle Cell Disease (SCD)
- A Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell Disease
- A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease
- A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD
- A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease
- Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease
- Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis
- Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease
- Acceptability of a New Paediatric Formulation of Hydroxycarbamide in Children With Sickle Cell Disease.
- Acceptability, Feasibility and Safety of a Yoga Program for Chronic Pain in Sickle Cell Disease
- Actigraphy Improvement With Voxelotor (ActIVe) Study
- Acupuncture for Adults With Sickle Cell Disease (SCD): A Feasibility Study
- Acupuncture for Pain in Sickle Cell Disease
- Acute Kidney Injury in Patients With Sickle Cell Disease
- Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease
- Adding Azathioprine/Hydroxyurea Preconditioning to Alemtuzumab/TBI to Reduce Risk of Graft Failure in MSD HSCT in Adult SCD Patients
- Addition of JSP191 (C-kit Antibody) to Non-myeloablative Hematopoietic Cell Transplantation For Sickle Cell Disease and Beta-Thalassemia
- Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease
- Adherence to HU and HRQOL in Patients With Sickle Cell Disease: An Intervention Study Using HU-Go App
- Adherence to Hydroxyurea in Children With Sickle Cell Anemia
- Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis
- Adolescent, Caregiver, and Young Adult Perspectives of the Transition From Pediatric to Adult Care for Sickle Cell Disease: A Preliminary Evaluation of the Sickle Cell Disease Transition Program
- Age of Blood in Sickle Cell Transfusion
- Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients
- Algorithm for Apherisis Monitoring and Prescription Assistance in Sickle Cell Patients (ALGODREP)
- Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs
- Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of Erythropoiesis
- Allogeneic Genoidentical Stem Cell Transplantation in Children With Sickle-cell Anemia and Cerebral Vasculopathy
- Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syndromes
- Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies
- Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies
- AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- Ameliorating Attention Problems in Children With Sickle Cell Disease (SCD)
- An Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia
- An Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001
- An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients
- An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
- Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD
- Androgen Regulation of Priapism in Sickle Cell Disease
- Angiotensin-converting Enzyme Inhibitors and Early Sickle Cell Renal Disease in Children
- Apixaban in Patients With Sickle Cell Disease
- Arginine Therapy for Sickle Cell Disease Pain
- Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- Aspirin Prophylaxis in Sickle Cell Disease
- Assessing Function in Pediatric Patients With Sickle Cell Disease
- Assessing the Safety of Buprenorphine in People With Sickle Cell Disease
- Assessment of Algorithm-Based Hydroxyurea Dosing on Fetal Hemoglobin Response, Acute Complications, and Organ Function in People With Sickle Cell Disease
- Assessment of Opioid Analgesia in Sickle Cell
- Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell Disease
- Autologous Bone Marrow Stem Cell Transplantation for Osteonecrosis in Sickle Cell Disease
- Autologous Bone Marrow Stem Cells for Chronic Leg Ulcer Treatment in Sickle Cell Disease
- Avascular Bone Necrosis in Sickle Cell Disease: a Pediatric Study.
- BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease
- BEATS 2: Music Therapy in Sickle Cell
- Bi-Level Positive Airway Ventilation for Acute Chest Syndrome
- Biological, Genetic and Environmental Involved in the Complications of Sickle Cell Disease
- Blood Collection for Research Related to Certain Diseases Involving Blood Vessels
- Blood Flow and Pain Crises in People With Sickle Cell Disease
- Blood Sampling for Research Related to Sickle Cell Disease
- Blood Transfusions in Thalassemia Patients, Complications and Adverse Effects
- Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
- Bone Marrow for Hemoglobinopathy Research
- Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies
- Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies
- Bone Marrow Transplantation in Treating Children With Sickle Cell Disease
- Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease
- Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
- Bone Marrow Transplantation, Hemoglobinopathies, SCALLOP
- Bone Pain in Adults With Sickle Cell Disease
- Brain Structure and Neurocognitive Development in Sickle Cell Disease; a Longitudinal Cohort Study (BRICK Study)
- Building Adaptive Coping and Knowledge to Improve Daily Life
- Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain
- Carbon Monoxide Levels and Sickle Cell Disease Severity
- Carbon Monoxide Measurement to Screen for Sickle Cell Disease
- Carbon Monoxide Monitor for the Measurement of End-Tidal Carbon Monoxide Levels in Children With or Without Hemolysis
- Cardiovascular Complications of Sickle Cell Disease
- CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation
- CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
- Central Nervous System Vascular Changes in Adult Sickle Cell Disease and the Effect of Treatment With Simvastatin
- Cerebral Oxygen Metabolism in Children
- Cerebrovascular Reserve and White Matter Disease in Patients With Chronic Anemia
- Cerebrovascular Reserve Measurements in Sickle Cell Disease
- Characteristics of Patients With Sickle Cell Disease
- CHOICES3: Sickle Cell Disease Parenting CHOICES
- Choosing Opioid Management for Pain and Analyzing Acute Chest Syndrome (ACS) Rates Equally
- Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia
- Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever
- Clinical Diagnosis of Teenagers Admitted to Pediatric Departments
- Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation
- Clinical Trial to Study the Safety and Tolerability of Memantin Mepha® in Sickle Cell Disease Patients
- Codeine in Sickle Cell Disease
- Cognitive Behavioral Therapy and Real-time Self-management Intervention for SCD Via Mobile Applications
- Cognitive Rehabilitation in Sickle Cell Disease
- Cognitive Remediation Intervention to Prepare for Transition of Care
- Collect of Cord Blood From Subjects at Risk for Sickle Cell Disease, for the Purpose of Laboratory Research
- Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell Disease
- Collection of Human Biospecimens for Basic and Clinical Research Into Alpha Globin Variants
- Combined Use of a Respiratory Broad Panel Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Hospitalized Sickle-cell Adults With Acute Chest Syndrome.
- Community Health Workers and mHealth for Sickle Cell Disease Care
- Comparing Acute Pain Management Protocols for Patients With Sickle Cell Disease
- Comparing Individualized vs. Weight Based Protocols to Treat VOE in SCD Occlusive Episodes in Sickle Cell Disease
- Comparison of Allogeneic Matched Related Haematopoietic Stem Cell Transplantation After a Reduced Intensity Conditioning Regimen With Standard of Care in Adolescents and Adults With Severe Sickle Cell Disease
- Comparison of Patient Centered Outcomes for People With Sickle Cell Disease in the Acute Care Setting
- Comparison of Patient Controlled Analgesia (PCA) Versus Bolus Narcotic Therapy for the Treatment of Vaso-Occlusive Crisis (VOC)
- Comparison of Two Methods of Transfusion for Stroke Prevention in Sickle Cell
- Computerized Cognitive Behavioral Therapy Assisted Life Management for Pain in Sickle Cell Disease
- Contraception in Women With Sickle Cell Disease
- Cooperative Assessment of Late Effects for SCD Curative Therapies
- Coordinated HEalthcare for Complex Kids
- COVID-19 Testing in Underserved and Vulnerable Populations
- COVID-19 Vaccine Response in Sickle Cell Disease
- Crizanlizumab Improves Tissue Oxygen Supply Demand Matching in Patients With Sickle Cell Anemia
- Curative Versus Disease-Modifying Therapies in Children With Severe Sickle Cell Disease
- Cutaneous Hydration Assessment in SCD
- Daily Vitamin D for Sickle-cell Respiratory Complications
- Decision Aid for Therapeutic Options In Sickle Cell Disease
- Decitabine for High-Risk Sickle Cell Disease
- Decompression Coring Versus Conservative Therapy in Patients With Avascular Necrosis of the Hip Related to Sickle Cell Disease
- Deferoxamine for Sickle Cell Chronic Leg Ulcer Treatment
- Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome
- Dense Red Blood Cells in Sickle Cell Children
- Designing an Implementation Strategy for Delivering Routine Mental Health Screening and Treatment
- Developing the Family Map: Looking at Communal Coping
- Disseminating NIH Evidence Based Sickle Cell Recommendations in North Carolina
- Dissemination and Implementation of Stroke Prevention Looking at the Care Environment
- Distracting Through Procedural Pain and Distress
- Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Patients With Acute Sickle Cell Crises?
- Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD
- Dose Ranging Study of Benserazide in Thalassemia Intermedia
- Dose-Escalation Study of SCD-101 in Sickle Cell Disease
- Dose-Finding Study of SC411 in Children With Sickle Cell Disease
- DREPAMASSE Study – Evaluation of a Newborn Screening for Sickle Cell Disease by Tandem Mass Spectrometry
- Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease
- Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects
- Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging
- Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell Transplantation
- Early Life Exposures Among Children With Sickle Cell Disease
- EDIT-301 for Autologous HSCT in Subjects With Severe Sickle Cell Disease
- Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease
- Effect of Exercise With and Without HMB on Body Composition and Muscle Strength in Sickle Cell Anaemia
- Effect of Inhaled Nitric Oxide in Acute Chest Syndrome (INOSTA Study)
- Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell Anemia
- Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease
- Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease
- Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
- Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease
- Effectiveness of Laying-on-of-hands for Sickle Cell Disease
- Effectiveness of New Analgesic Strategy Compared to the Usal Antalgic Strategy
- Effects of HQK-1001 in Patients With Sickle Cell Disease
- Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell Anemia
- Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
- Effects of Transfusion of Older Stored Red Cells
- Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
- Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease
- Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease
- Efficacy, Safety Study and Benefit of Alkali Therapy in Sickle Cell Disease
- ElectroNic Hydroxyurea AdhereNCE: A Strategy to Improve Hydroxyurea Adherence in Patients With Sickle Cell Disease
- Empowering Adolescents and Young Adults With Sickle Cell Disease as Partners in Treatment Decision Making (EMPOWER-AYA)
- Endothelial Function in Patients With Sickle Cell Anemia Before and After Sildenafil
- Endothelial Monocyte-activating Polypeptide-II in Egyptian Sickle Patients
- Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators
- Epidemiology and Pathophysiological Mechanisms of HTAP in SS and SC Children in Martinique and Guadeloupe.
- Epidemiology of Silent and Overt Strokes in Sickle Cell Disease
- Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease
- ESCORT-HU Extension: European Sickle Cell Disease Cohort – Hydroxyurea – Extension Study
- Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell Disease
- European Sickle Cell Disease Cohort – Hydroxyurea
- Evaluating Barriers to Stroke Screening and Prevention in Children With Sickle Cell Disease
- Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601)
- Evaluating Thromboelastography (TEG) and ETP in Sickle Adults
- Evaluation of a Training Program for Homozygous Sickle Cell Disease Patients
- Evaluation of Different Dose Regimens of Aes-103 Given for 28 Days to Subjects With Stable Sickle Cell Disease
- Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia
- Evaluation of Impact of Disease on Quality of Life, Education and Socio-professional Integration of Adults and Parents of Children Living With Sickle- Cell Disease in France
- Evaluation of Knowledge Among Adolescents With Sickle Cell Disease.
- Evaluation of Left Ventricular Function by Speckle Tracking Echocardiography in Patient Hospitalised in Intensive Care Unit for Vaso-occlusive Crisis
- Evaluation of Low-cost Techniques for Detecting Sickle Cell Disease and β-thalassemia in Nepal
- Evaluation of Nocturnal Enuresis and Barriers to Treatment Among Pediatric Patients With Sickle Cell Disease
- Evaluation of Non-invasive Endothelial Function in Children Sickle by Vascular Ultrasound
- Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
- Evaluation of Repeat Administration of Purified Poloxamer 188
- Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)
- Evaluation of Sickle Cell Liver Disease
- Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients
- Evaluation of the AMICUS RBCx System in Sickle Cell Patients
- Evaluation of the Hemostatic Potential in Sickle Cell Disease Patients
- Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)
- Evaluation of the Lung Capillary Blood Volume in Children With Sickle Cell Disease
- Evaluation of the Prevalence of Pulmonary Hypertension in Adult Patients With Sickle Cell Disease
- Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO).
- Evaluation of Therapeutic Adherence to Inciting Spirometry in Sickle Cell Patients
- Evaluation of Virtual Reality to Save Morphinic in the Treatment of Vaso-occlusive Seizures of Sickle Cell Patients Consulting in the Emergency Room
- Examining the Knowledge, Attitudes, and Beliefs of Sickle Cell Disease Patients, Parents of Patients With Sickle Cell Disease, and Providers Towards the Integration of CRISPR in Clinical Care
- Exercise Capacity in Pediatric Sickle Cell Anemia
- Exercise in Child Health
- Exercise-induced Pulmonary Hypertension in Patients With Sickle-cell Anemia
- Exhaled Carbon Monoxide as a Marker of Hemolysis in Sickle Cell Disease- an Exploratory Study
- Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
- Expanded Access Protocol for Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment Options
- Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options
- Exploring Adherence Monitoring in Sickle Cell Disease
- EXTEND EXpanding Treatment for Existing Neurological Disease
- Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
- Families Taking Control (FTC): Family-based Problem-solving Intervention for Children With Sickle Cell Disease
- Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
- Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD)
- Feasibility of a Stress Reduction Intervention Study in Sickle Cell Disease
- Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome
- Fetal Hemoglobin Induction Treatment Metformin
- Fitness Trial in Adults With Sickle Cell Disease (SCD Fit): A Feasibility Study
- FOCUS for Pediatric Sickle Cell Disease and Cancer
- Functional and Mechanistic Characterization of Limb Ulcers in Patients With Sickle Cell Disease
- Functional Neuroimaging of Pain Using EEG and fMRI
- Gaming Technology to Engage Adolescent Sickle Cell Patients in Pain Management
- GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD)
- Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
- Gene Transfer for Patients With Sickle Cell Disease
- Gene Transfer for Sickle Cell Disease
- Genes Influencing Iron Overload State
- Glucose Metabolism in Sickle Cell Disease
- Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD Patients
- Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension
- Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell Anemia
- Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease
- Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMT CTN 1507)
- Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Severe Sickle Cell Disease
- Haploidentical PBMC Transplant for Severe Congenital Anemias
- Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Ultrasound
- Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease
- Health Literacy – Neurocognitive Screening in Pediatric SCD
- Heart Arteries and Sickle Cell Disease / Coeur Artères DREpanocytose
- Heart Disease in Sickle Cell Anemia
- Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies
- Hematopoietic Stem Cell Transplant for Sickle Cell Disease
- Hemoglobin Desaturation in Sickle Cell Disease
- Hemoglobinopathy Nursing Program and Pediatric Nursing Students
- Hemolysis Related Complications in SCD. A Phase II Study With Voxelotor
- Hepcidin Levels in Sickle Cell Disease (SCD)
- High-flow Oxygen for Vaso-occlusive Pain Crisis
- High-Tc Susceptometer to Monitor Transfusional Iron Overload
- HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease
- HLA-Identical Sibling Donor Bone Marrow Transplantation for Individuals With Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen
- Home Based Massage and Relaxation for Sickle Cell Pain
- Home-based Assessment of PRO Measures in SCD Using A Smartphone App Platform: A Feasibility Study
- Home-Based Intervention for Chronic Pain in Adults With Sickle Cell Disease
- Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide
- HRV-B for Symptom Management in Sickle Cell Patients
- HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity
- Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain
- Hydoxycarbamide and L-Carnitine Therapy in Sickle Cell Anemia
- Hydoxyurea Exposure in Lactation A Pharmacokinetics Study (HELPS)
- Hydroxyurea Adherence for Personal Best in Sickle Cell Disease (HABIT): Efficacy Trial
- Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT
- Hydroxyurea and EPO in Sickle Cell Disease
- Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia
- Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease
- Hydroxyurea and Transfusion
- Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
- Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension
- Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia
- Hydroxyurea in the Treatment of Sickle Cell Disease
- Hydroxyurea in Young Children With Sickle Cell Anemia
- Hydroxyurea Management in Kids: Intensive Versus Stable Dosage Strategies
- Hydroxyurea Optimization Through Precision Study
- Hydroxyurea Therapy: Optimizing Access in Pediatric Populations Everywhere
- Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
- Hyperbaric Oxygen Therapy in Sickle Cell Pain
- Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD)
- Hypnosis to Manage Pain and Symptoms in Patients With Sickle Cell Disease
- Ibuprofen and Opioid (Morphine or Diamorphine) for Acute Pain in Sickle Cell Disease – Sickle With Ibuprofen & Morphine
- iCanCope With Sickle Cell Pain
- Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text Messaging
- Imatinib for Pain in Sickle Cell Anemia
- Immunogenicity Study of an Anti-pneumococcal Vaccination Strategy in Patients With Sickle Cells Disease
- Impact on the Length of Stay in Incentive Spirometry and Pain in the Decompensation of Sickle Cell Disease: .
- IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome
- Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE’s in Sickle Cell Disease
- Implication of the Oxydative Stress in the Pathophysiology of Sickle Cell Anemia:
- Implications of a Paediatrician-psychologist Tandem for Sickle Cell Disease Care and Impact on Cognitive Functioning
- Improving Disease Knowledge in Adolescents With Sickle Cell Disease
- Improving Emergency Department Management of Adults With Sickle Cell Disease
- Improving Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease
- Improving Quality by Maintaining Accurate Problems in the EHR
- Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia
- Improving Self-Management in Adolescents With Sickle Cell Disease
- Improving Sickle Cell Disease (SCD) Care Using Web-based Guidelines
- Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias
- Inflammation, Platelets and Sickle Cell Disease
- Inflammatory Response to Hydroxyurea Therapy in Sickle Cell Disease
- Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial
- Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2
- Inhaled Mometasone to Reduce Painful Episodes in Patients With Sickle Cell Disease
- Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
- Integration of mHEALTH Into the Care of Patients With Sickle Cell Disease to Increase Hydroxyurea Utilization
- Integrative Medicine in Pain Management in Sickle Cell Disease
- Interest of Famotidine in Children With Sickle Cell Disease
- Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
- Intermittent Preventive Treatment for Malaria in Patient With Sickle Cell Disease
- Intranasal Fentanyl Versus Intravenous Morphine in the Treatment of Severe Painful Sickle Cell Crises in Children
- Intranasal Ketamine For Pain Control In Patients With Sickle Cell Disease And Vaso-occlusive Episode (VOE) In The PED
- Intravenous Gammaglobulin for Sickle Cell Pain Crises
- Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis
- Invasive Infections in Children With Hemoglobinopathies
- Investigation of the Genetics of Hematologic Diseases
- iPeer2Peer Program for Youth With Sickle Cell Disease
- Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia
- Is the Preoperative Preparation of Sickle Cell Patients Optimal: Assessment of Practices and Post-operative Complications
- Isoquercetin in Sickle Cell Anemia
- Ketamine as an Adjuvant Therapy for Acute Vaso Occlusive Crisis in Pediatric Patients With Sickle Cell Disease
- Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients
- Ketamine Infusion for Acute Sickle Cell Crisis in the Emergency Department
- Ketamine Sickle Cell Disease
- Kid Cards: Teaching Kids About Medicines
- Kidney Function in Sickle Cell Anemia
- Kidney Transplantation in Patients With Sickle Cell Disease
- L-Arginine and Sickle Cell Disease
- L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity
- L-Glutamine Therapy for Sickle Cell Anemia
- L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia
- Laboratory-based Hypnosis Intervention on Pain Responsivity in Adolescents With Sickle Cell Disease
- LCI-HEM-SCD-ST3P-UP-001: The Sickle Cell Trevor Thompson Transition Project (ST3P-UP Study)
- Lidocaine for Sickle Cell Crisis Pain in the Emergency Department
- Links Between Cognitive Functions and Clinical, Biological and Neuroradiological Outcomes in Adults With Sickle Cell Disease.
- Liver Fibrosis in Sickle Cell Disease
- Long Term Effects of Erythrocyte Lysis
- Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease
- Long Term Follow up in Sickle Cell Patients Treated by Hydroxyurea
- Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Sickle Cell Anemia
- Long-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy
- Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias
- Longitudinal Changes in Exercise Capacity in Children and Young Adults With Sickle Cell Anemia
- Longterm Follow-up of Subjects With Hemoglobinopathies Treated With Ex Vivo Gene Therapy
- Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease
- Losartan for Sickle Cell Kidney Disease
- Losartan to Reverse Sickle Nephropathy
- Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE)
- Low Dose Iron Chelation as TReatment of Oxidative Damage in Sickle Cell Disease
- Low Dose Ketamine and Acute Pain Crisis
- Low-Dose Ketamine Infusion for Children With Sickle Cell Disease-Related Pain
- Macitentan in Pulmonary Hypertension of Sickle Cell Disease
- Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease
- MACS Study – Microparticles and Coagulation in Sickle Cell Disease
- Management of Severe Acute Malnutrition in SCD, in Northern Nigeria
- MAP to Provide Access to Crizanlizumab, for Sickle Cell Disease Patients
- Measurement of Cerebral Blood Flow Using Transcranial Doppler Ultrasound in Children With Sickle Cell Disease
- Measures of Respiratory Health (MRH)
- Medication Adherence and Non-adherence in Adults With Rare Disease
- Medication Adherence in Youth With Sickle Cell Disease (SCD)
- Mesenchymal Stromal Cells for Haplo Hematopoietic Cell Transplantation for Sickle Cell Disease
- Methadone in Pediatric and Adult Sickle Cell Patients
- Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease
- Microvascular Blood Flow in Sickle Cell Anemia
- Microvessels and Heart Problems in Sickle Cell Disease
- Mindfulness and Yoga Therapy for Acute Pain in Sickle Cell Disease
- Minimizing Toxicity in HLA-identical Related Donor Transplantation for Children With Sickle Cell Disease
- Minocycline In Neurocognitive Outcomes – Sickle Cell Disease
- Mobile-Directly Observed Therapy on Adherence to Hydroxyurea
- Moderate Dose Hydroxyurea for Secondary Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa
- Molecular Phenotyping of Asthma in Sickle Cell Disease
- Monocytic Expression of Heme Oxidase-1 (HO-1) in Sickle Cell Patients and Correlation With the Humoral Immune Response to Vaccine and With Allo-immunization.
- Motivations, Expectations, and Decision-making of Sickle Cell Patients in Clinical Research
- Motixafortide and Natalizumab to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease (SCD)
- Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations
- Muscle Function and Its Biological and Physiological Determinants in Sickle Cell Disease
- Music Therapy in Sickle Cell Pain Mixed Methods Study
- Music Therapy in Sickle Cell Transition Study
- MUSic Therapy to Improve Quality Of Life in Sickle Cell Disease (MUSIQOLS)
- Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
- N-Acetylcysteine in Patients With Sickle Cell Disease
- Nasopharyngeal Bacterial Carriage and Antibiotic Resistance in Children With Sickle Cell Disease in Ile-De-France
- Near Infrared Spectroscopy in Sickle Cell Pediatric Patients
- Neuropathic Pain in Jamaicans With Sickle Cell Disease
- Neurovascular Determinants of Cognitive Function in Adults With Sickle Cell Disease
- Neutrophil Extracellular Traps and Sickle Cell Disease
- New Hemolysis Parameters in Sickle Cell Disease
- Niacin to Improve Blood Flow in People With Sickle Cell Disease
- Nitric Oxide and Sickle Cell Pain
- Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension
- Nitric Oxide Therapy for Acute Chest Syndrome in Sickle Cell Disease Children
- Nitric Oxide to Improve Blood Flow in Sickle Cell Disease
- Nitrous Oxide Analgesia Vaso-occlusive Crisis
- Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders
- Non-Myeloablative Conditioning and Bone Marrow Transplantation
- Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease
- Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease
- Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure
- Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor
- Novel Cardiac Magnetic Resonance Imaging to Define a Unique Restrictive Cardiomyopathy in Sickle Cell Disease
- Novel Dose Escalation to Predict Treatment With Hydroxyurea
- Novel Use Of Hydroxyurea in an African Region With Malaria
- Obesity in Pediatric Sickle Cell Disease: A New Phenomenon
- Observational Prospective Study Measuring the Impact of the Use of a Hypnotic Script Associated With Virtual Reality on the Pain of the Child’s Sickle Cell During a Vaso-occlusive Crisis
- Observational Study of Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
- Omega-3 Fatty Acids in Sickle Cell Disease
- Optimizing Hydroxyurea Therapy in Children With SCA In Malaria Endemic Areas
- Oral Magnesium Pidolate, Hemoglobin SC Disease, MG Pidolate
- Osteopathic Manipulation in the Management of Pain Associated With Sickel Cell Disease
- Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD
- Oxygen Therapy and Pregnancy in Sickle Cell Disease
- Pain Management in Children and Young Adults With Sickle Cell Disease
- Pain Management Protocol for Pediatric Sickle Cell Disease
- Parent Educational Program for Children With Sickle Cell Disease
- Parent Willingness to Participate in Tobacco Trials in the Pediatric Clinical Setting
- Pathophysiology of Acute Pain in Patients With Sickle Cell Disease
- Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell Disease
- PATient Navigator to rEduce Readmissions
- Patient-Provider Tools to Improve the Transition to Adult Care in Sickle Cell Disease
- Pediatric -Adult Care Transition Program of Patients With Sickle Cell Disease
- Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II Protocol
- Pediatric Open-Label Extension of Voxelotor
- Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
- Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients
- Peripheral Blood Stem Cell Collection From Patients With Sickle Cell Disease (SCD) Using Plerixafor
- PET Imaging of Vaso-Occlusive (VOC) in SCD
- Ph I/II Study of Allogeneic SCT for Clinically Aggressive Sickle Cell Disease (SCD)
- Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products
- Pharmacokinetics (PK) of Liquid Hydroxyurea in Pediatric Patients With Sickle Cell Anemia
- Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease
- Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC)
- Pharmacokinetics and Safety of Endari (L-glutamine) in Sickle Cell Disease Patients
- Pharmacokinetics of Oral Hydroxyurea Solution
- Phase 1 Study of Zoledronic Acid in Sickle Cell Disease
- Phase 1/2 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HQK-1001 Administered Daily in Patients With Sickle Cell Disease
- Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis
- Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
- Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia
- Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers
- Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease
- Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension
- Physical Rehabilitation in Sickle Cell Anemia
- Pilates Physical Activity in Sickle Cell Disease
- Pilot Study for Patients With Poor Response to Deferasirox
- Pilot Study of Fructose for Sickle Cell Crisis
- Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease
- Pilot Study PBSCT With TCRab Depletion for Hemoglobinopathies
- PINPOINT: Gaming Technology for SCD Pain
- PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease
- PK Study of Ticagrelor in Children Aged Less Than 24 Months, With Sickle Cell Disease (HESTIA4)
- Plasma DNA and Vascular Remodelling in Patients With Sickle Cell Disease
- Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth Outcome
- Prasugrel Versus Placebo in Adult Sickle Cell Disease
- Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies
- Predictors and Outcomes in Patients With Sickle Cell Disease
- Preliminary Feasibility and Efficacy of Behavioral Intervention to Reduce Pain-Related Disability in Pediatric SCD
- Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCD.
- Prevalence and Pathophysiology of Systemic Arterial Pressure Abnormalities in Childhood Sickle Cell Disease
- Prevalence Of Microalbuminuria Among Children Suffering From Sickle Cell Nephropathy and Sickle Cell/Beta-Thalassemia
- Prevalence of Osteoporosis in Sickle Cell Disease
- Prevalence of Problematic Use of Equimolar Mixture of Oxygen and Nitrous Oxide and Analgesics in the Sickle-cell Disease
- Preventing Acute Chest Syndrome by Transfusion Feasibility Study
- Preventing Sickle Cell Kidney Disease
- Prevention Of Morbidity In Sickle Cell Disease Pilot Phase
- Prevention of Vaso-occlusive Painful Crisis by Using Omega-3 Fatty Acid Supplements
- Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II
- Primary Prevention of Stroke in Children With Sickle Cell Anaemia in Nigeria in the Community
- Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa
- Propanolol and Red Cell Adhesion Non-asthmatic Children Sickle Cell Disease
- Prospective, Observational Study in Sickle Cell Disease Patients on Crizanlizumab Treatment in Middle East Countries and India
- Psychometric Evaluation of the IPPAQ in Pediatric Patients With Sickle Cell Disease Hospitalized With Vasoocclusive Pain
- Pulmonary Hypertension in Patients With Sickle Cell Disease in Nigeria
- Pulmonary Hypertension, Hypoxia and Sickle Cell Disease
- Qualitative Survey of Potential Exercise Activity in Adults With Sickle Cell Anemia (SCA)
- Quality of Care of Children With Sickle Cell Disease (SCD) Screened at Birth in France
- Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell Disease
- Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant
- Ranibizumab for Neovascularization in Sickle Cell Retinopathy
- Re-Aiming at Hydroxyurea Adherence for Sickle Cell With mHealth
- Realizing Effectiveness Across Continents With Hydroxyurea (REACH)
- Red Blood Cell – IMProving trAnsfusions for Chronically Transfused Recipients
- Red Blood Cell Survival in Sickle Cell Disease
- Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease
- Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
- Reduced Intensity Transplantation for Severe Sickle Cell Disease
- Regional Anesthesia for Sickle Cell Crisis Using Ultrasound in The Emergency Department: Phase I
- Rejuvesol® Washed RBC in Sickle Cell Patients Requiring Frequent Transfusions
- RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease
- Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET
- Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism Levels
- Research Study Investigating How Well NDec Works in People With Sickle Cell Disease
- Resolution of Sickle Cell Leg Ulcers With Voxelotor
- Retrospective Real World Oxbryta® Data Collection and Analysis Study
- RH Genotype Matched RBC Transfusions
- RHD Genotype Matching for Anti-D
- Rifaximin to Modify the Disease Course in Sickle Cell Disease
- Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea Treatment
- Risk Factors for Allo-immunization in Sickle Cell Disease
- Risk-based Therapy for Sickle Cell Anemia: A Feasibility Study
- Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD)
- Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
- SACRED A Prospective Research Study to Reduce Stroke in Children With Sickle Cell Anemia
- Safety and Efficacy of Gene Therapy of the Sickle Cell Disease by Transplantation of an Autologous CD34+ Enriched Cell Fraction That Contains CD34+ Cells Transduced ex Vivo With the GLOBE1 Lentiviral Vector Expressing the βAS3 Globin Gene in Patients With Sickle Cell Disease (DREPAGLOBE)
- Safety and Efficacy of Sodium Nitrite in Sickle Cell Disease
- Safety and Pharmacokinetics of SANGUINATE™ in Sickle Cell Disease (SCD) Patients
- Safety Evaluation of DREPADOM – Home Care Services and Hospitalizations for Sickle Cell Disease Patients
- Safety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell Disease
- Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
- Safety of Single Ascending Doses of CSL889 in Adult Patients With Stable Sickle Cell Disease
- Safety Study of MP4CO in Adult Sickle Cell Patients
- Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Study of ALXN1820 in Adult Participants With Sickle Cell Disease
- Safety, Pharmacokinetic, and Pharmacodynamic Study of NKTT120 in Adult Patients With Stable Sickle Cell Disease (SCD)
- Safety, Tolerability and Pharmacokinetics of FTX-6058
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FTX-6058
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Multiple Oral Doses of AG-348 in Subjects With Stable Sickle Cell Disease
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat
- SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease
- SCD Fit Homebase Program
- SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD
- SCD-PROMIS: A Software Platform to Enhance Self-efficacy and Patient-provider Engagement for Patients With Sickle Cell Pain
- Screening for Subjects to Participate in Studies of Blood Disorders
- Screening Patients With Sickle Cell Disease for Kidney Damage
- Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
- SELF-BREATHE RCT for Chronic Breathlessness
- Self-Management for Youth and Families Living With SCD – SMYLS
- Severe Acute Respiratory Syndrome CoV 2 COVID-19 Survey and Vaccination Coverage in the Sickle Cell Population in Ile-De-France
- Sevuparin Infusion for the Management of Acute VOC in Subjects With SCD
- Shared-Decision Making for Hydroxyurea
- Sickle Cell Anemia – A Comparative Study Between Three Ethnical Communities, a Multicenter Study
- Sickle Cell Anemia and Cerebral Microcirculation : Multimodal Exploration
- Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel
- Sickle Cell Anemia Screening and Prevention in Northern Israel
- Sickle Cell Anemia WE CARE
- Sickle Cell Clinical Research and Intervention Program
- Sickle Cell Disease – Stroke Prevention in Nigeria Trial
- Sickle Cell Disease (SCD) Decision Aid
- Sickle Cell Disease and CardiovAscular Risk – Red Cell Exchange Trial (SCD-CARRE)
- Sickle Cell Disease and Endothelial Progenitor Cells (EPCs)
- Sickle Cell Disease and the Genomic Needs of Parent and Pediatric Stakeholders
- Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
- Sickle Cell Disease Conditioning for Bone Marrow Transplant
- Sickle Cell Disease Obstetric Multi-Disciplinary Care Programme: Prospective Multi-Centre Cohort Study
- Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial
- Sickle Cell Disease, Hemechip
- Sickle Cell Disease, Neurocognitive Disorders, Social Participation
- Sickle Cell Disease: A Retrospective Chart Review
- Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics
- Sickle Cell Hemoglobinopathies and Bone Health
- Sickle Cell Improvement: Enhancing Care in the Emergency Department
- Sickle Cell Pain: Intervention With Capsaicin Exposure
- Sickle Cell Pro-Inflammatory Response to Interval Training Study
- Sickle Cell Uric Acid (SCUA) – Cohort Repository
- Sickle-cell Disease Registry of the GPOH
- SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)
- Sildenafil for Treatment of Priapism in Men With Sickle Cell Anemia
- Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
- Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial
- Simvastatin (Zocor) Therapy in Sickle Cell Disease
- Single-center Prospective Evaluation of Sickle Cell Patient Care in the CHU Brugmann Emergency Department
- Sleep and Pain in Sickle Cell Disease
- Sleep Apnea in Sickle Cell Disease
- Sleep Respiratory Disorders Evaluation in Sickle Cell Disease Children
- Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal Events
- SMART Mobile Application Technology Utilization in the Treatment of Sickle Cell Disease Post Day Hospital Discharge
- SMYLS: A Self-management Program for Youth Living With Sickle Cell Disease
- Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)
- Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease
- sPLA2 in EBC During Acute Chest Syndrome
- State Of The Art Functional Imaging In Sickle Cell Disease
- Stem Cell Gene Therapy for Sickle Cell Disease
- Stem Cell Transplant for Hemoglobinopathy
- Stem Cell Transplant in Patients With Severe Sickle Cell Disease
- Stem Cell Transplant in Sickle Cell Disease and Thalassemia
- Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia
- Stem Cell Transplantation for Sickle Cell Anemia
- Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell Disease
- Steroid Treatment for Sickle Cell Pain Crisis
- Stigma, Self-management, & Quality of Life in SCD
- Stroke Prevention in Young Adults With Sickle Cell Anemia
- Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease
- Study of a Red Blood Cell Deformability Parameter in Patients With Sickle Cell Disease
- Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders
- Study of an Intervention to Improve Problem List Accuracy and Use
- Study of Beet Juice for Patients With Sickle Cell Anemia
- Study of Biological Markers in Children With Sickle Cell Disease
- Study of Blood Platelets in Sickle Cell Disease
- Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)
- Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes
- Study of Crizanlizumab for Prevention of Silent Cerebral Infarcts in SCA
- Study of Decitabine and Tetrahydrouridine (THU) in Patients With Sickle Cell Disease
- Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients
- Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients
- Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell Anemia
- Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload
- Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA)
- Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation
- Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
- Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
- Study of Hydroxyurea to Treat Sickle Cell Disease
- Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease
- Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
- Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell Disease
- Study of MGTA-145 and Plerixafor in Patients With Sickle Cell Disease
- Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- Study of Propranolol as Anti-Adhesive Therapy in Sickle Cell Disease (SCD)
- Study of Safety and Efficacy of Genome-edited Hematopoietic Stem and Progenitor Cells in Sickle Cell Disease (SCD)
- Study of SANGUINATE™ Versus Hydroxyurea in Sickle Cell Disease (SCD) Patients
- Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
- Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients
- Study of Ventilatory Mechanics in Patients With Sickle Cell Anemia
- Study of Vitamin D in Children With Sickle Cell Disease
- Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises
- Study to Assess the Effect of Long-term Treatment With GBT440 in Participants Who Have Completed Treatment in Study GBT440-031
- Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease
- Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease
- Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.
- Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE)
- Sub-dissociative Intranasal Ketamine for Pediatric Sickle Cell Pain Crises
- Substudy of CADRE: for People With Extreme Phenotype: BIOCADRE
- Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell Anemia
- Survey in a Population of Sickle Cell Disease Patients to Evaluate the Transition Between the Queen Fabiola Children Hospital and the CHU Brugmann Hospital, and the Quality of the Hospital Care Within the CHU Brugmann Hospital.
- T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
- Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia
- TAPS2 Transfusion Antenatally in Pregnant Women With SCD
- The Afolabi Stroke Registry for Children and Young Adults With SCD in Northern Nigeria
- The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2
- The Effect of Rivaroxaban in Sickle Cell Disease
- The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell Anemia
- The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease
- The Feasibility of the PAINReportIt Guided Relaxation Intervention-INPATIENT
- The Feasibility of the PAINReportIt Guided Relaxation Intervention-Outpatient
- The Implementation of the Automated Erythrocytapheresis in Egyptian Sickle Cell Disease Center
- THE IMPROVE TRIAL: Improving Pain Management and Outcomes With Various Strategies of Patient-Controlled Analgesia (PCA)
- The Link Between Anemia and Deficits in Memory and Attention in Individuals With Sickle Cell Disease
- The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.
- The Montreal Cognitive Assessment.Test in Adults With Sickle Cell Disease
- The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia
- The Role of Endothelin-1 in Sickle Cell Disease
- The Spleen in Sickle Cell Anemia and Sickle Cell Thalassemia
- The Use of Warmed Saline in Vaso-occlusive Episodes
- Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease
- THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)
- TMLI and Alemtuzumab for Treatment of Sickle Cell Disease
- To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease
- Tocilizumab Acute Chest
- Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients With Blood Disorders
- Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers
- Transcranial Doppler (TCD) With Transfusions Changing to Hydroxyurea
- Transfusion Alternatives Pre-Operatively in Sickle Cell Disease (TAPS)
- Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization
- Transfusion in Sickle Cell Disease: Screening of Sickle Cell Disease Trait in Blood Donors
- Transillumination Device for Peripheral Intravenous Placement in Patients With Sickle Cell Disease (PERFID)
- Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease
- Transplantation Using Reduced Intensity Approach for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow
- Treatment of Adult Patients With Hemoglobin SC Disease (SCYTHE)
- Treatment of Hemoglobin SC Disease
- Treatment of Sickle Cell Anemia With Stem Cell Transplant
- Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo
- TRF-1101 Assessment in Sickle Cell Disease
- Trial of Zileuton CR in Children and Adults With Sickle Cell Disease
- Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell Anemia
- US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease
- Use of a Mobile-based App for SCD Patients
- Use of Mobile Technology for Intensive Training in Medication Management
- Using Patient-Centered Guidelines in a Technology Platform to Improve Health Care in Adults With Sickle Cell Disease
- Utilizing A Single Session Problem-Solving Intervention With Caregivers of Pediatric Patients Receiving Chronic Transfusion to Treat Sickle Cell Disease
- Validating Pain Scales in Children and Young Adults
- Validation of the Sickle Cell Disease Pain Burden Interview
- Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease
- Vascular Function Intervention Trial in Sickle Cell Disease
- Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait
- Vitamin D and Bisphosphonates in the Treatment of Sickle Cell Disease
- Vitamin D for Sickle Cell
- Vitamin D for Sickle-cell Respiratory Complications
- Vitamin D Status in Children With Sickle Cell Disease Living in Lyon, France
- Vitamin D Supplementation in Children With Sickle Cell Disease
- Vitamin D3 in Patients With Sickle Cell Disease
- Voxelotor Cerebral Hemodynamics Study
- Voxelotor Neurocognitive Function Study
- Voxelotor Sickle Cell Exercise Study
- Web-MAP Intervention for Youth With Sickle Cell Disease
- Working Memory and School Readiness in Preschool-Aged Children With Sickle Cell Disease
- Zinc for Infection Prevention in Sickle Cell Anemia (ZIPS)
- Zinc Supplementation in Children With Sickle Cell Disease in Western Kenya
- Comprehensive Risk Assessment of People With Silicosis: A Population-based Study
- DNA-damage Pathways in Workers Exposed to Silica (Caesar Stone)
- Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention
- Efficiency of Pirfenidone for the Reduction of Pulmonary Metabolic, Inflammatory and Fibrogenic Activity in Patients With Silicosis Due to Artificial Stone and Progressive Massive Fibrosis
- Oscillation Mechanics of the Respiratory System in Never-smoking Patients With Silicosis
- Oxidative Stress Biomarkers to Monitor and Early Detect Health Impairment in Workers Exposed to Silica (Caesar Stone)
- Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis
- Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma
- Silicosis Treatment, Action, Screening and Surveillance in Rwanda Trials
- Specialized Center of Research in Occupational and Immunologic Lung Disease
- The Nintedanib in Progressive Pneumoconiosis Study (NiPPS): a Collaborative NSW Treatment Trial
- The SHIELD Study-silicosis
- The SHIELD Whole Lung Lavage Study
- Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Disease
- Factors Associated With Normal Exercise Capacity in Patients With Single Ventricle
- Impact of Exercise Training on Single Ventricle Function in Paediatric Fontan Patients
- Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease
- A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)
- A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)
- Effects of Fish Oil and Colesevelam (STAIR7007)
- Genetic Study of Sitosterolemia
- Sitosterolemia Metabolism
- The Effect of Dietary Sitosterol on Blood Sugar and Cholesterol